Paris - Delayed Quote EUR
DBV Technologies S.A. (DBV.PA)
At close: 5:14 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-103,024.0000
-79,653.0000
-55,666.0000
-108,242.0000
-165,607.0000
Investing Cash Flow
-1,950.0000
-808.0000
-100.0000
-433.0000
-2,865.0000
Financing Cash Flow
-1,121.0000
6,767.0000
194,120.0000
274.0000
149,548.0000
End Cash Position
67,867.0000
141,367.0000
209,194.0000
77,301.0000
196,352.0000
Capital Expenditure
-2,469.0000
-677.0000
-754.0000
-918.0000
-2,817.0000
Issuance of Capital Stock
-872.0000
6,921.0000
194,594.0000
978.0000
150,449.0000
Repayment of Debt
--
--
--
--
-303.0000
Repurchase of Capital Stock
--
-154.0000
--
--
-563.0000
Free Cash Flow
-105,493.0000
-80,330.0000
-56,420.0000
-109,160.0000
-168,424.0000
12/31/2020 - 3/29/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SIGHT.PA GenSight Biologics S.A.
0.3120
-0.95%
IPH.PA Innate Pharma S.A.
1.6260
+0.25%
GNFT.PA Genfit S.A.
4.9000
-9.09%
OSE.PA OSE Immunotherapeutics SA
9.95
-1.09%
PHXM.PA PHAXIAM Therapeutics S.A.
1.7900
-0.22%
ALCLS.PA Cellectis S.A.
1.7040
+0.95%
VLA.PA Valneva SE
2.4160
-3.75%
POXEL.PA Poxel S.A.
0.2615
-4.04%
ALTHX.PA Theranexus Société Anonyme
0.5080
+0.40%
GNFT Genfit S.A.
5.31
-5.85%